Limited Art Edition 2025
2025 TAG Limited Art Edition To purchase this unique work, please use this form.
2025 Pipeline Report
Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).
HCV Storyboard: Sibusiso Dlamini
This Hepatitis C virus (HCV) storyboard describes the experience of Sibusiso Dlamini in Tsawne, South Africa. Sibusiso is a young man who began using substances for leisure in high school, and later in life switched to injecting substances for a stronger high.
An Activist’s Guide to Diagnostic Tools for Tuberculosis 2025
The World Health Organization (WHO) guidelines for diagnosing TB have evolved along with available technologies and tools that are increasingly accurate, simple, and efficient at detecting TB and resistance to a wider range of TB drugs.
2024 Annual Report
I’m proud to share with you TAG’s 2024 Annual Report. Last year already seems long ago with all the attacks on research and health care, domestic and international, which are currently taking place under the new administration...
Brick by Brick: A Brief Guide to Protecting Your Community’s Health with Direct Action
TAG's Senior TB Project Associate, Erin McConnell, created this 'zine about TAG for Pride 2025. It's about fighting back, and goes over current threats, action items, and action steps on how to show up.
Story: HIV cure “breakthrough” with mRNA-delivered Tat protein
June 2025 Media coverage: Breakthrough in search for HIV cure leaves researchers ‘overwhelmed’ - Kat Lay, The Guardian, June 5, 2025 Major breakthrough in battle for HIV cure ‘previously thought impossible’ - Athena Stavrou, Independent, June 5, 2025 Used in…
Treatment Action Group Statement on Termination of HIV Vaccine Research Funding
On Friday May 30, it was reported that National Institutes of Health (NIH) leadership has unilaterally terminated funding for HIV vaccine research consortia that were making significant progress toward solving the stern challenge of inducing protective broadly neutralizing antibodies against the virus.
WEBINAR: TB Treatment’s New Frontier: Orienting Community to Long-Acting Injectables for TB
On June 5, 2025, TAG and WHO cohosted a webinar orienting people to long-acting injectables for TB treatment and prevention. Long-acting Injectables (LAIs) have the potential to revolutionize treatment for TB and other infectious diseases.
An Ethical and Legal Crisis: Treatment Action Group (TAG) Statement on the Withholding of NIH Funding for HIV Clinical Research Networks
TAG demands immediate action by the National Institutes of Health (NIH) to provide Congressionally appropriated and committed funding to the HIV clinical research networks (ACTG, HPTN, HVTN, IMPAACT).